Economic Advantages of Domestic Production of Biosimilar Medicines in Iran

Background: Biosimilars can be considered generic versions of branded biologic medicines. Substituting branded biologic medicines with biosimilars is important to reduce medication costs. In addition to reducing drug costs, the domestic production of biosimilars can provide many other economic benef...

Full description

Bibliographic Details
Main Authors: Nazila Yousefi, Behniya Azadmehr, Seyyed Ali Hashemi, Mohammadhossein Motevali Khameneh, Farzad Peiravian
Format: Article
Language:fas
Published: Shahid Sadoughi University of Medical Sciences 2023-09-01
Series:Rāhburdhā-yi Mudīriyyat dar Niẓām-i Salāmat
Subjects:
Online Access:http://mshsj.ssu.ac.ir/article-1-653-en.pdf